News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
413,188 Results
Type
Article (33181)
Company Profile (64)
Press Release (379940)
Multimedia
Podcasts (75)
Webinars (7)
Section
Business (113253)
Career Advice (1334)
Deals (24174)
Drug Delivery (108)
Drug Development (60033)
Employer Resources (105)
FDA (10229)
Job Trends (9134)
News (212702)
Policy (25744)
Tag
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (1848)
Accelerated approval (29)
Adcomms (26)
Allergies (108)
Alliances (42398)
ALS (120)
Alzheimer's disease (1343)
Antibody-drug conjugate (ADC) (247)
Approvals (10364)
Artificial intelligence (338)
Autoimmune disease (100)
Automation (21)
Bankruptcy (238)
Best Places to Work (7693)
BIOSECURE Act (16)
Biosimilars (153)
Biotechnology (42)
Bladder cancer (113)
Brain cancer (57)
Breast cancer (434)
Cancer (3538)
Cardiovascular disease (283)
Career advice (1139)
Career pathing (23)
CAR-T (191)
CDC (53)
Cell therapy (521)
Cervical cancer (26)
Clinical research (50868)
Collaboration (1408)
Company closure (3)
Compensation (977)
Complete response letters (54)
COVID-19 (2595)
CRISPR (62)
C-suite (399)
Cystic fibrosis (87)
Data (4401)
Decentralized trials (1)
Denatured (12)
Depression (102)
Diabetes (387)
Diagnostics (3734)
Digital health (23)
Diversity (8)
Diversity, equity & inclusion (34)
Drug discovery (178)
Drug pricing (176)
Drug shortages (31)
Duchenne muscular dystrophy (193)
Earnings (42768)
Editorial (53)
Employer branding (13)
Employer resources (98)
Events (48347)
Executive appointments (435)
FDA (12468)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (8)
Frontotemporal dementia (17)
Funding (929)
Gene editing (138)
Generative AI (32)
Gene therapy (460)
GLP-1 (937)
Government (4367)
Grass and pollen (6)
Guidances (303)
Healthcare (11436)
HIV (49)
Huntington's disease (39)
IgA nephropathy (63)
Immunology and inflammation (182)
Immuno-oncology (44)
Indications (74)
Infectious disease (2848)
Inflammatory bowel disease (117)
Inflation Reduction Act (11)
Influenza (109)
Intellectual property (158)
Interviews (233)
IPO (10546)
IRA (46)
Job creations (1756)
Job search strategy (959)
JPM (44)
Kidney cancer (10)
Labor market (48)
Layoffs (338)
Leadership (20)
Legal (7099)
Liver cancer (68)
Longevity (14)
Lung cancer (494)
Lymphoma (287)
Machine learning (32)
Management (33)
Manufacturing (562)
MASH (136)
Medical device (6068)
Medtech (6092)
Mergers & acquisitions (14480)
Metabolic disorders (1077)
Multiple sclerosis (113)
NASH (20)
Neurodegenerative disease (237)
Neuropsychiatric disorders (70)
Neuroscience (2244)
Neurotech (1)
NextGen: Class of 2026 (3663)
Non-profit (2792)
Now hiring (9)
Obesity (555)
Opinion (240)
Ovarian cancer (108)
Pain (119)
Pancreatic cancer (179)
Parkinson's disease (214)
Partnered (24)
Patents (313)
Patient recruitment (292)
Peanut (43)
People (25668)
Pharmaceutical (20)
Pharmacy benefit managers (20)
Phase 1 (15366)
Phase 2 (22093)
Phase 3 (17930)
Pipeline (3856)
Policy (271)
Postmarket research (1846)
Preclinical (6387)
Press Release (28)
Prostate cancer (174)
Psychedelics (42)
Radiopharmaceuticals (231)
Rare diseases (641)
Real estate (2609)
Recruiting (47)
Regulatory (17903)
Reports (24)
Research institute (1630)
Resumes & cover letters (196)
Rett syndrome (26)
RNA editing (9)
RSV (80)
Schizophrenia (120)
Series A (128)
Series B (102)
Service/supplier (3)
Sickle cell disease (61)
Special edition (11)
Spinal muscular atrophy (147)
Sponsored (27)
Startups (1913)
State (1)
Stomach cancer (13)
Supply chain (79)
Tariffs (71)
The Weekly (62)
Vaccines (1015)
Venture capital (61)
Weight loss (385)
Women's health (53)
Worklife (11)
Date
Today (37)
Last 7 days (373)
Last 30 days (1271)
Last 365 days (19630)
2026 (1801)
2025 (19914)
2024 (22352)
2023 (25257)
2022 (33380)
2021 (35890)
2020 (34075)
2019 (27909)
2018 (21234)
2017 (20187)
2016 (18692)
2015 (21495)
2014 (15948)
2013 (12876)
2012 (13623)
2011 (14401)
2010 (13078)
Location
Africa (583)
Alabama (50)
Alaska (3)
Arizona (124)
Arkansas (5)
Asia (26965)
Australia (4838)
California (6797)
Canada (2028)
China (785)
Colorado (272)
Connecticut (304)
Delaware (239)
Europe (64722)
Florida (1029)
Georgia (217)
Hawaii (4)
Idaho (30)
Illinois (486)
India (47)
Indiana (330)
Iowa (17)
Japan (339)
Kansas (76)
Kentucky (24)
Louisiana (17)
Maine (32)
Maryland (971)
Massachusetts (4816)
Michigan (163)
Minnesota (241)
Mississippi (1)
Missouri (78)
Montana (21)
Nebraska (11)
Nevada (73)
New Hampshire (27)
New Jersey (2042)
New Mexico (15)
New York (1938)
North Carolina (811)
North Dakota (5)
Northern California (3394)
Ohio (189)
Oklahoma (9)
Oregon (14)
Pennsylvania (1364)
Puerto Rico (12)
Rhode Island (17)
South America (806)
South Carolina (32)
South Dakota (1)
Southern California (2634)
Tennessee (85)
Texas (877)
United States (24003)
Utah (158)
Vermont (1)
Virginia (170)
Washington D.C. (43)
Washington State (527)
West Virginia (2)
Wisconsin (60)
Wyoming (2)
413,188 Results for "orthogen ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
FDA
FDA approves Orthogen’s IDE
Orthogen AG , a leader in molecular medicine, announces U.S. Food and Drug Administration (FDA) approval of an Investigational Device Exemption (IDE) for the company’s proprietary technology, Orthogen® Device (OD).
January 18, 2023
·
2 min read
Press Releases
Memo Therapeutics AG’s Potravitug Granted Orphan Designation in the European Union
December 18, 2025
·
3 min read
Press Releases
Telomir Pharmaceuticals Reports New Data Supporting an Epigenetic Modulation Mechanism Implicated in Cancer and Aging
February 5, 2026
·
7 min read
Startups
Six Startups Changing The Way We Age
Armed with the latest biological knowledge and cutting-edge computational techniques—and, of course, investor dollars—these six biotechs are playing in the largely underappreciated longevity space, developing therapies that may improve the quality of aging.
July 9, 2025
·
11 min read
·
Tristan Manalac
Press Releases
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
February 2, 2026
·
3 min read
Press Releases
Idorsia’s daridorexant in women during menopausal transition age with insomnia
January 6, 2026
·
12 min read
Startups
Longevity Biotechs Strive for Better Aging—Not Just Life Extension
The industry sector focused on aging is only about 10 years old, but acting on what scientists already know, a new crop of biotechs, backed by investors, are taking a disease-centric approach to extending the human lifespan.
July 9, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Curing the Incurable with ‘Biological Age Zero’ Cells: Clonell™ Launches the Ultimate Regenerative Medicine Platform
January 5, 2026
·
5 min read
Collaboration
Alphabet Subsidiary Calico Colors In Up To $570M+ Aging Deal With China’s Mabwell
Calico will leverage 9MW3811’s anti-inflammatory mechanism to advance its mission of addressing aging-related diseases.
June 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age
January 28, 2026
·
5 min read
1 of 41,319
Next
